Teva snags Auspex Pharmaceutical for $3.5B, PTC acquires ColdLight (Morning Read)
TOP STORIES Teva has completed its $3.5-billion purchase of Auspex Pharmaceuticals – still keeping an eye on Mylan, though. PTC announced it has signed a definitive agreement to acquire ColdLight, a visionary in big data machine learning and predictive analytics, for approximately $105 million. LIFE SCIENCE A plant-derived compound could target cancer stem cells. […]